David J. Stewart

15.8k total citations · 3 hit papers
315 papers, 10.8k citations indexed

About

David J. Stewart is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, David J. Stewart has authored 315 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Oncology, 120 papers in Pulmonary and Respiratory Medicine and 100 papers in Molecular Biology. Recurrent topics in David J. Stewart's work include Lung Cancer Treatments and Mutations (82 papers), Lung Cancer Research Studies (40 papers) and Cancer Treatment and Pharmacology (36 papers). David J. Stewart is often cited by papers focused on Lung Cancer Treatments and Mutations (82 papers), Lung Cancer Research Studies (40 papers) and Cancer Treatment and Pharmacology (36 papers). David J. Stewart collaborates with scholars based in Canada, United States and United Kingdom. David J. Stewart's co-authors include Razelle Kurzrock, Ignacio I. Wistuba, Filip Jankú, Stephen G. Swisher, Carmen Behrens, Robert S. Benjamin, Jean A. Maroun, J. Jack Lee, Frances A. Shepherd and John B. Dunning and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

David J. Stewart

302 papers receiving 10.4k citations

Hit Papers

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincr... 1999 2026 2008 2017 1999 2013 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
    1999 694 citations David J. Stewart et al. Journal of Clinical Oncology profile →
  2. Wnt Signaling Pathway in Non-Small Cell Lung Cancer
    2013 533 citations David J. Stewart profile →
  3. Mechanisms of resistance to cisplatin and carboplatin
    2007 517 citations David J. Stewart profile →

Peers

David J. Stewart
W. Gillies McKenna United States
Malcolm A. Smith United States
Susan M. Blaney United States
Gregory H. Reaman United States
Alice P. Chen United States
Jacqueline Whang‐Peng Taiwan
Taylor Murray United States
Lutz Edler Germany
Edward P. Gelmann United States
Lu Wang China
W. Gillies McKenna United States
David J. Stewart
Citations per year, relative to David J. Stewart David J. Stewart (= 1×) peers W. Gillies McKenna

Countries citing papers authored by David J. Stewart

Since Specialization
Citations

This map shows the geographic impact of David J. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Stewart more than expected).

Fields of papers citing papers by David J. Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Stewart. The network helps show where David J. Stewart may publish in the future.

Co-authorship network of co-authors of David J. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Stewart. A scholar is included among the top collaborators of David J. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Stewart. David J. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stewart, David J., Sandeep Sehdev, Vishal Navani, et al.. (2024). New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices. Current Oncology. 31(5). 2453–2480. 5 indexed citations
2.
Mittal, Abhenil, Sara Moore, Vishal Navani, et al.. (2024). What Is Ailing Oncology Clinical Trials? Can We Fix Them?. Current Oncology. 31(7). 3738–3751. 3 indexed citations
3.
Monti, Francesco, David J. Stewart, Anuradha Surendra, et al.. (2023). Signed Distance Correlation (SiDCo): an online implementation of distance correlation and partial distance correlation for data-driven network analysis. Bioinformatics. 39(5). 9 indexed citations
4.
Kenney, Matthew, et al.. (2023). Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials. Current Oncology. 30(9). 8310–8327. 12 indexed citations
5.
Fung‐Kee‐Fung, Michael, Bill Davies, Stephanie Pick, et al.. (2022). Cancer Clinic Redesign: Opportunities for Resource Optimization. Current Oncology. 29(6). 3983–3995.
6.
Bennett, Alexandria, P A Campbell, Gareth Palidwor, et al.. (2022). Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study. Current Oncology. 29(8). 5238–5246. 7 indexed citations
7.
Stewart, David J., et al.. (2022). Treatment Access, Health Economics, and the Wave of a Magic Wand. Current Oncology. 29(2). 1176–1189. 3 indexed citations
8.
Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies. Cancer Research. 77(10). 2686–2698. 91 indexed citations
9.
Morgan‐Linnell, Sonia K., David J. Stewart, & Razelle Kurzrock. (2014). U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009. Clinical Cancer Research. 20(13). 3364–3370. 10 indexed citations
10.
Behrens, Carmen, Luisa M. Solis, Heather Lin, et al.. (2013). EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clinical Cancer Research. 19(23). 6556–6565. 123 indexed citations
11.
Jankú, Filip, Donald A. Berry, Jing Gong, et al.. (2012). Outcomes of Phase II Clinical Trials with Single-Agent Therapies in Advanced/Metastatic Non–Small Cell Lung Cancer Published between 2000 and 2009. Clinical Cancer Research. 18(22). 6356–6363. 20 indexed citations
12.
Stewart, David J.. (2010). Lung Cancer. Humana Press eBooks. 4 indexed citations
13.
Stewart, David J., Simon N. Whitney, & Razelle Kurzrock. (2010). Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research. Journal of Clinical Oncology. 28(17). 2925–2935. 76 indexed citations
14.
Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations
15.
Cormier, Yvon, E. Eisenhauer, A. Muldal, et al.. (1994). Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). Annals of Oncology. 5(3). 283–285. 123 indexed citations
16.
Gregg, Richard, et al.. (1992). Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.. Journal of Clinical Oncology. 10(5). 795–803. 289 indexed citations
17.
Feun, Lynn G., Moshe Maor, David J. Stewart, et al.. (1990). Pilot Study of PCNU and Cranial Radiation Therapy in the Treatment of Patients with Malignant Gliomas. Oncology. 47(5). 389–392. 2 indexed citations
18.
Stewart, David J., et al.. (1987). Theoretical and Applied Ethics. 22(1). 5–11. 4 indexed citations
19.
Nanji, Amin A., Nadia Z. Mikhael, & David J. Stewart. (1986). Hypoalbuminemia in Patients Receiving Cisplatin: Correlation between Liver Platinum and Decrease in Serum Albumin. Oncology. 43(1). 33–35. 8 indexed citations
20.
Stewart, David J., Robert S. Benjamin, & Mario A. Luna. (1982). Human tissue vinblastine (V) and cisplatin (CP). Proceedings of the American Association for Cancer Research. 23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Gillies McKenna Breakdown of academic impact, for papers by Malcolm A. Smith Breakdown of academic impact, for papers by Susan M. Blaney Breakdown of academic impact, for papers by Gregory H. Reaman Breakdown of academic impact, for papers by Alice P. Chen Breakdown of academic impact, for papers by Jacqueline Whang‐Peng Breakdown of academic impact, for papers by Taylor Murray Breakdown of academic impact, for papers by Lutz Edler Breakdown of academic impact, for papers by Edward P. Gelmann Breakdown of academic impact, for papers by Lu Wang
Rankless by CCL
2026